RE: Clinical applications of bone morphogenetic proteins: current evidence. Kanakaris, NK; Giannoudis, PV; JSOA 17(3):133-46, 2008.
Smoljanovic
Tomislav
T
Smoljanovic
Tomislay
T
Caric
Davor
D
Caric
David
D
Bojanic
Ivan
I
D019485:Bone Morphogenetic Proteins / Q000009:adverse effects*; D001862:Bone Resorption / Q000139:chemically induced*; D016025:Bone Transplantation / Q000379:methods*; D006801:Humans; D011994:Recombinant Proteins / Q000009:adverse effects*; D013123:Spinal Fusion / Q000009:adverse effects / Q000379:methods*
D019485:Bone Morphogenetic Proteins; D011994:Recombinant Proteins